Shares of both Ultragenyx and Mereo BioPharma were seeing record selloffs after disappointing trial results for setrusumab.

The study reports on the development of core–shell magnetic nanocomposites coated with bioactive glass for combined bone cancer therapy and regeneration of the injured bone area. The magnetic ...

Palliative radiation therapy for high-risk asymptomatic bone metastases significantly prolonged OS while reducing skeletal-related events compared with standard therapy, phase 2 trial results showed.

Ultragenyx Pharmaceutical said on Monday that late-stage studies showed its drug for a type of genetic bone disease failed to ...

Bone stimulators are a therapy that may help with bone healing in certain situations. However, the debate is still out on their effectiveness. Devices such as bone stimulators are often used for ...

To determine the association between nonextraction clear aligner therapy and the presence of alveolar bone defects, CBCT images from 29 adults were obtained before and immediately after therapy. From ...

Trial investigators report lower risks for skeletal-related events, hospitalization, and death. Prophylactic radiation therapy delivered to patients with high-risk asymptomatic bone metastases from ...

Lab tests show that bioactive glasses combined with gallium oxide have a 99% success rate in eliminating bone cancer cells and can even regenerate diseased bone. The corresponding study was published ...

Bone health during breast cancer treatment can be a concern, but there are ways to reduce the impact. If a person is at risk for a loss of bone density, doctors can prescribe medications. Lifestyle ...

At the time, we simply accepted this as 'old age'. Today, we understand that one of the major culprits behind this dramatic ...